SEC Form 4 · accession 0001437749-18-013568
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roderick De Greef
Officer — Chief Financial Officer
Period of report
Jul 18, 2018
Accepted (ET)
Jul 20, 2018 · 5:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 18, 2018 | M | 10,000 | $1.8099 | A | 24,583 | D | |
| Common StockF2 | Jul 18, 2018 | S | 10,000 | $20.00 | D | 14,583 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF4 | $1.8099 | Jul 18, 2018 | M | 10,000 | D | — | May 3, 2026 | Common Stock | 10,000 | 224,000 | D |
| Employee Stock OptionF3 | $1.64 | holding | — | — | — | — | Dec 20, 2021 | Common Stock | 136,919 | 136,919 | D |
| Employee Stock OptionF5 | $1.76 | holding | — | — | — | — | Mar 4, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2018.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.95 to $20.10, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3The stock option vests and becomes exercisable as follows: 85,960 shares vested on March 8, 2018 and 85,959 shares will vest on March 8, 2019.
- F4The stock option vests 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter.
- F5The stock option vests 25% on the first anniversary of the grant date and thereafter, in 36 equal monthly installments. Such options shall continue to vest regardless of whether Mr. de Greef's service with the Company continues.